Rheacell
Manufacturing · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Im Neuenheimer Feld 517, Heidelberg, Bad...Phone Number
+49 6221718330Website
www.rheacell.comRevenue
$5.4 MillionIndustry
About Rheacell
Rheacell Org Chart
Is Rheacell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Rheacell launches new products
Check out if Rheacell is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Rheacell had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Rheacell has new funding data
Earning: See what the market has to say on Rheacell recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Rheacell
Rheacell, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Rheacell has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Rheacell as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Rheacell is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rheacell is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rheacell.
Rheacell Tech Stack
A closer look at the technologies used by Rheacell
Most Recent Scoops
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rheacell
RHEACELL is a fully integrated biopharmaceutical company based in Heidelberg, Germany, specializing in innovative stem cell therapies for patients with severe inflammation-driven diseases, particularly rare conditions like Epidermolysis Bullosa. With over 20 years of experience, the company focuses on developing proprietary ABCB5+ mesenchymal strom... Read More